Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline for Treatment of E-cigarette Dependence

NCT05541497 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05541497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05541497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline for Treatment of E-cigarette Dependence
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
November 4, 2022
Completion date
September 1, 2023
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation